Please login to the form below

Not currently logged in
Email:
Password:

German partners find diabetes biomarker

Helmholtz Zentrum München and Boehringer Ingelheim have identified a biomarker for diabetes-relevant protein

Helmholtz Zentrum München and Boehringer Ingelheim have jointly identified a biomarker for diabetes-relevant protein.

The indicator will enable the pre-clinical testing of FABP4 inhibitors, therefore facilitating the selection of potentially effective substances. Studies on human subjects and mouse models show that the FABP4 protein could be a potential target protein for new drugs to treat diabetes mellitus and atherosclerosis.

The biomarker was found through the use of lipidomics and metabolomics. Scientists at the Helmholtz Zentrum München were the first to use the modern lipidomics technologies to successfully identify such functionally relevant biomarkers for FABP4.

Boehringer Ingelheim provided the necessary biological and indication-specific knowledge; the Helmholtz Zentrum München contributed expertise in metabolomics and bioinformatics.

The development of the biomarker for FABP4 was the pilot project for the collaborative research venture to identify functional biomarkers.

19th May 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics